<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-LE9J7LKF</identifier><date>1993</date><creator>Fleischmann, W.R.</creator><creator>Novaković, Srdjan</creator><relation>documents/doc/L/URN_NBN_SI_doc-LE9J7LKF_001.pdf</relation><relation>documents/doc/L/URN_NBN_SI_doc-LE9J7LKF_001.txt</relation><format format_type="volume">27</format><format format_type="issue">4</format><format format_type="type">article</format><format format_type="extent">str. 286-292</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID_HOST">2254553</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-LE9J7LKF</identifier><language>eng</language><publisher publisher_location="[Zagreb]">Croatian Medical Association - Croatian Society of Radiology</publisher><publisher publisher_location="Ljubljana">Slovenian Medical Society - Section of Radiology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>InC</rights><subject language_type_id="slv">Drug administration routes</subject><subject language_type_id="slv">Interferon alfa, recombinant</subject><subject language_type_id="slv">Melanoma, experimental</subject><subject language_type_id="slv">Mice</subject><title>Antitumor effect on interferon-alpha administered by different routes of treatment</title></Record>